Seyed Hamid Sayar, MD - Medicare Hematology/oncology in Avon, IN

Seyed Hamid Sayar, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Avon, Indiana. He graduated from medical school in 1984 and has 40 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice Indiana University Health Care Associates Inc, University Medical Diagnostic Associates Inc and his current practice location is 1111 Ronald Reagan Pkwy, Avon, Indiana. You can reach out to his office (for appointments etc.) via phone at (317) 944-0920.

Seyed Hamid Sayar is licensed to practice in Indiana (license number 01063818A) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1851430862.

Contact Information

Seyed Hamid Sayar, MD
1111 Ronald Reagan Pkwy,
Avon, IN 46123-7085
(317) 944-0920
(317) 968-1137



Physician's Profile

Full NameSeyed Hamid Sayar
GenderMale
SpecialityHematology/oncology
Experience40 Years
Location1111 Ronald Reagan Pkwy, Avon, Indiana
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Seyed Hamid Sayar graduated from medical school in 1984
  NPI Data:
  • NPI Number: 1851430862
  • Provider Enumeration Date: 02/06/2007
  • Last Update Date: 06/27/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 8123111622
  • Enrollment ID: I20071030000332

Medical Identifiers

Medical identifiers for Seyed Hamid Sayar such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1851430862NPI-NPPES
200877950MedicaidIN
P00472630OtherINRRMC UMDA TIN
P01550973OtherINRRMC IUHP TIN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0000XInternal Medicine - Hematology MD2004-0601 (New Mexico)Secondary
207RH0003XInternal Medicine - Hematology & Oncology 01063818A (Indiana)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Indiana University HealthIndianapolis, INHospital
Indiana University Health Tipton Hospital IncTipton, INHospital
Iu Health West HospitalAvon, INHospital
Indiana University Health North HospitalCarmel, INHospital
Indiana University Health Ball Memorial HospitalMuncie, INHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Indiana University Health Care Associates Inc5799755864882
University Medical Diagnostic Associates Inc3375446347279

News Archive

Reaction to UNAIDS/WHO report on HIV/AIDS

Health officials on Tuesday reacted to a report from UNAIDS and the World Health Organization showing that the number of people living with HIV/AIDS over the past two years has increased and that the worldwide total now stands at nearly 40 million, the New York Times reports (Altman, New York Times, 11/22).

Tribogenics closes $6.2M Series A financing round

Tribogenics, a producer of innovative X-ray sources, announced today that it has closed a $6.2 million Series A financing round led by Founders Fund. The company previously received $2.5M in funding from Flywheel Ventures and other angel investors.

Eribulin from marine sponge inhibits replication of breast cancer cells

For more than three decades a new drug for the treatment of breast cancer had not been presented. A group of researchers were given the task of analyzing a marine sponge called Halichondrin okadai and obtained a mesylate eribulin substance that had already been applied to patients with this disease in the stage of metastasis, ie, when the disease spreads to other body parts and the result was that it inhibited tumor growth.

Removable methyl groups on specific genes of autistic individuals that led to gene silencing identified

A new study by researchers at The George Washington University School of Medicine and Health Sciences' Department of Biochemistry and Molecular Biology raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought.

Systagenix introduces WOUNDCHEK system at EWMA 2011

Systagenix, the home of the Let's Heal system, attended the 2011 European Wound Management Association conference (EWMA) in Belgium and introduced the WOUNDCHEK brand; the umbrella brand name of its soon to be launched point of care tests, to an international audience of over 2,500 clinicians.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Seyed Hamid Sayar allows following entities to bill medicare on his behalf.
Entity NameUniversity Medical Diagnostic Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1861441537
PECOS PAC ID: 3375446347
Enrollment ID: O20040202000510

News Archive

Reaction to UNAIDS/WHO report on HIV/AIDS

Health officials on Tuesday reacted to a report from UNAIDS and the World Health Organization showing that the number of people living with HIV/AIDS over the past two years has increased and that the worldwide total now stands at nearly 40 million, the New York Times reports (Altman, New York Times, 11/22).

Tribogenics closes $6.2M Series A financing round

Tribogenics, a producer of innovative X-ray sources, announced today that it has closed a $6.2 million Series A financing round led by Founders Fund. The company previously received $2.5M in funding from Flywheel Ventures and other angel investors.

Eribulin from marine sponge inhibits replication of breast cancer cells

For more than three decades a new drug for the treatment of breast cancer had not been presented. A group of researchers were given the task of analyzing a marine sponge called Halichondrin okadai and obtained a mesylate eribulin substance that had already been applied to patients with this disease in the stage of metastasis, ie, when the disease spreads to other body parts and the result was that it inhibited tumor growth.

Removable methyl groups on specific genes of autistic individuals that led to gene silencing identified

A new study by researchers at The George Washington University School of Medicine and Health Sciences' Department of Biochemistry and Molecular Biology raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought.

Systagenix introduces WOUNDCHEK system at EWMA 2011

Systagenix, the home of the Let's Heal system, attended the 2011 European Wound Management Association conference (EWMA) in Belgium and introduced the WOUNDCHEK brand; the umbrella brand name of its soon to be launched point of care tests, to an international audience of over 2,500 clinicians.

Read more Medical News

› Verified 3 days ago

Entity NameIndiana University Health Care Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1902032832
PECOS PAC ID: 5799755864
Enrollment ID: O20040727000955

News Archive

Reaction to UNAIDS/WHO report on HIV/AIDS

Health officials on Tuesday reacted to a report from UNAIDS and the World Health Organization showing that the number of people living with HIV/AIDS over the past two years has increased and that the worldwide total now stands at nearly 40 million, the New York Times reports (Altman, New York Times, 11/22).

Tribogenics closes $6.2M Series A financing round

Tribogenics, a producer of innovative X-ray sources, announced today that it has closed a $6.2 million Series A financing round led by Founders Fund. The company previously received $2.5M in funding from Flywheel Ventures and other angel investors.

Eribulin from marine sponge inhibits replication of breast cancer cells

For more than three decades a new drug for the treatment of breast cancer had not been presented. A group of researchers were given the task of analyzing a marine sponge called Halichondrin okadai and obtained a mesylate eribulin substance that had already been applied to patients with this disease in the stage of metastasis, ie, when the disease spreads to other body parts and the result was that it inhibited tumor growth.

Removable methyl groups on specific genes of autistic individuals that led to gene silencing identified

A new study by researchers at The George Washington University School of Medicine and Health Sciences' Department of Biochemistry and Molecular Biology raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought.

Systagenix introduces WOUNDCHEK system at EWMA 2011

Systagenix, the home of the Let's Heal system, attended the 2011 European Wound Management Association conference (EWMA) in Belgium and introduced the WOUNDCHEK brand; the umbrella brand name of its soon to be launched point of care tests, to an international audience of over 2,500 clinicians.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Seyed Hamid Sayar is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Seyed Hamid Sayar, MD
250 N Shadeland Ave, Ste 130 Provider Enrollment,
Indianapolis, IN 46219-4959

Ph: () -
Seyed Hamid Sayar, MD
1111 Ronald Reagan Pkwy,
Avon, IN 46123-7085

Ph: (317) 944-0920

News Archive

Reaction to UNAIDS/WHO report on HIV/AIDS

Health officials on Tuesday reacted to a report from UNAIDS and the World Health Organization showing that the number of people living with HIV/AIDS over the past two years has increased and that the worldwide total now stands at nearly 40 million, the New York Times reports (Altman, New York Times, 11/22).

Tribogenics closes $6.2M Series A financing round

Tribogenics, a producer of innovative X-ray sources, announced today that it has closed a $6.2 million Series A financing round led by Founders Fund. The company previously received $2.5M in funding from Flywheel Ventures and other angel investors.

Eribulin from marine sponge inhibits replication of breast cancer cells

For more than three decades a new drug for the treatment of breast cancer had not been presented. A group of researchers were given the task of analyzing a marine sponge called Halichondrin okadai and obtained a mesylate eribulin substance that had already been applied to patients with this disease in the stage of metastasis, ie, when the disease spreads to other body parts and the result was that it inhibited tumor growth.

Removable methyl groups on specific genes of autistic individuals that led to gene silencing identified

A new study by researchers at The George Washington University School of Medicine and Health Sciences' Department of Biochemistry and Molecular Biology raises hope that autism may be more easily diagnosed and that its effects may be more reversible than previously thought.

Systagenix introduces WOUNDCHEK system at EWMA 2011

Systagenix, the home of the Let's Heal system, attended the 2011 European Wound Management Association conference (EWMA) in Belgium and introduced the WOUNDCHEK brand; the umbrella brand name of its soon to be launched point of care tests, to an international audience of over 2,500 clinicians.

Read more News

› Verified 3 days ago


Internal Medicine Doctors in Avon, IN

Bhasker Reddy, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1115 N Ronald Reagan Parkway, Suite 206, Avon, IN 46123
Phone: 317-272-8050    Fax: 317-272-8051
Namrata Shah, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1111 Ronald Reagan Pkwy Ste B1500, Avon, IN 46123
Phone: 317-217-2244    Fax: 317-217-2249
Graham D Dellinger, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123
Phone: 317-217-2888    Fax: 317-217-2999
Caitlin M Baxter, MD
Hematology & Oncology
Medicare: Medicare Enrolled
Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123
Phone: 317-962-5820    Fax: 317-962-3916
Dr. Stephen H Pollom, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1115 Ronald Reagan Pkwy, Ste 318, Avon, IN 46123
Phone: 317-217-2600    Fax: 317-217-2606
Dr. David Lee Hyslop, MD
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 6013 Yellow Birch Ct, Avon, IN 46123
Phone: 317-838-7096    
Michaela A Besold, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 8244 E Us Highway 36, Suite 1320, Avon, IN 46123
Phone: 317-272-7519    Fax: 317-272-3661

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.